Literature DB >> 10368066

Ketosis and epilepsy: 31P spectroscopic imaging at 4.1 T.

J W Pan1, E M Bebin, W J Chu, H P Hetherington.   

Abstract

PURPOSE: To determine whether changes in the high-energy phosphates occur with use of the ketogenic diet in patients with intractable epilepsy.
METHODS: 31P magnetic resonance spectroscopic imaging studies were performed at 4.1 T in seven patients with intractable epilepsy (four Lennox-Gastaut syndrome, one absence, one primary generalized tonic-clonic, and one partial complex) before and after institution of the ketogenic diet. Coronal 1H anatomic imaging also was performed to provide correlation to the 31P data.
RESULTS: Taking the patients as a group, the ratio of phosphocreatine (PC)/gamma-adenosine triphosphate (ATP) measured at baseline (regular diet) compared with that measured after the ketogenic diet showed a small but significant increase from 0.61+/-0.08 to 0.69+/-0.08 (p < 0.05). Comparing the ratio of PCr inorganic phosphorus (Pi) measured at baseline with the postketogenic diet, there was a significant increase from 2.45+/-0.27 to 2.99+/-0.44 (p < 0.05).
CONCLUSIONS: As a group, improvement of energy metabolism occurs with use of the ketogenic diet. This is in agreement with the chronic ketosis studies performed earlier in rodents.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10368066     DOI: 10.1111/j.1528-1157.1999.tb00766.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  29 in total

Review 1.  Astrocytic regulation of glutamate homeostasis in epilepsy.

Authors:  Douglas A Coulter; Tore Eid
Journal:  Glia       Date:  2012-05-16       Impact factor: 7.452

2.  Purines and the Anti-Epileptic Actions of Ketogenic Diets.

Authors:  Susan A Masino; Masahito Kawamura; David N Ruskin; Jeremy Gawryluk; Xuesong Chen; Jonathan D Geiger
Journal:  Open Neurosci J       Date:  2010-01-01

3.  Dietary approaches to epilepsy treatment: old and new options on the menu.

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2004 Nov-Dec       Impact factor: 7.500

4.  Redistribution of monocarboxylate transporter 2 on the surface of astrocytes in the human epileptogenic hippocampus.

Authors:  Fredrik Lauritzen; Kjell Heuser; Nihal C de Lanerolle; Tih-Shih W Lee; Dennis D Spencer; Jung H Kim; Albert Gjedde; Tore Eid; Linda H Bergersen
Journal:  Glia       Date:  2012-04-25       Impact factor: 7.452

5.  The ketogenic diet: stoking the powerhouse of the cell.

Authors:  Jong M Rho; Michael A Rogawski
Journal:  Epilepsy Curr       Date:  2007 Mar-Apr       Impact factor: 7.500

Review 6.  The ketogenic diet in a pill: is this possible?

Authors:  Jong M Rho; Raman Sankar
Journal:  Epilepsia       Date:  2008-11       Impact factor: 5.864

Review 7.  Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?

Authors:  Susan A Masino; Jonathan D Geiger
Journal:  Trends Neurosci       Date:  2008-05-09       Impact factor: 13.837

Review 8.  Adenosine and Ketogenic Treatments.

Authors:  David N Ruskin; Masahito Kawamura; Susan A Masino
Journal:  J Caffeine Adenosine Res       Date:  2020-09-16

Review 9.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

10.  Decreased astroglial monocarboxylate transporter 4 expression in temporal lobe epilepsy.

Authors:  Bei Liu; Le Niu; Ming-Zhi Shen; Lei Gao; Chao Wang; Jie Li; Li-Jia Song; Ye Tao; Qiang Meng; Qian-Li Yang; Guo-Dong Gao; Hua Zhang
Journal:  Mol Neurobiol       Date:  2014-01-25       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.